Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$13.9M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 4 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 27 most recent Form 4 transactions.
| $376.6K |
| -1.3% |
| Open the original filing on SEC.gov |
| Jun 30 | KYMR | Kymera Therapeutics, Inc. | SSELL◷ | 6,153 | $116.99 | $719.9K | -2.4% | Open the original filing on SEC.gov |
| Jun 30 | KYMR | Kymera Therapeutics, Inc. | SSELL◷ | 7,971 | $115.82 | $923.2K | -3.0% | Open the original filing on SEC.gov |
| Jun 30 | KYMR | Kymera Therapeutics, Inc. | SSELL◷ | 51,375 | $114.77 | $5.9M | -16.4% | Open the original filing on SEC.gov |
| Jun 30 | KYMR | Kymera Therapeutics, Inc. | SSELL◷ | 4,110 | $114.19 | $469.3K | -1.3% | Open the original filing on SEC.gov |
| Jun 30 | KYMR | Kymera Therapeutics, Inc. | SSELL◷ | 1,100 | $112.79 | $124.1K | -0.4% | Open the original filing on SEC.gov |
| Jun 30 | KYMR | Kymera Therapeutics, Inc. | SSELL◷ | 1,700 | $111.57 | $189.7K | -0.5% | Open the original filing on SEC.gov |
| Jun 30 | KYMR | Kymera Therapeutics, Inc. | SSELL◷ | 1,500 | $110.54 | $165.8K | -0.5% | Open the original filing on SEC.gov |
| Jun 30 | KYMR | Kymera Therapeutics, Inc. | MEXER◷ | 61,378 | $5.33 | $327.1K | +23.5% | Open the original filing on SEC.gov |
| Jun 2 | KYMR | Kymera Therapeutics, Inc. | MEXER◆ | 12,653 | — | — | — | Open the original filing on SEC.gov |
| Jun 2 | KYMR | Kymera Therapeutics, Inc. | MEXER | 12,653 | $2.08 | $26.3K | +5.1% | Open the original filing on SEC.gov |
| May 18 | KYMR | Kymera Therapeutics, Inc. | MEXER◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |
| May 18 | KYMR | Kymera Therapeutics, Inc. | MEXER | 15,000 | $2.08 | $31.2K | +6.5% | Open the original filing on SEC.gov |
| Mar 4 | KYMR | Kymera Therapeutics, Inc. | SSELL | 447 | $86.62 | $38.7K | -0.2% | Open the original filing on SEC.gov |
| Mar 4 | KYMR | Kymera Therapeutics, Inc. | SSELL | 1,437 | $85.78 | $123.3K | -0.6% | Open the original filing on SEC.gov |
| Mar 4 | KYMR | Kymera Therapeutics, Inc. | SSELL | 2,519 | $85.04 | $214.2K | -1.1% | Open the original filing on SEC.gov |
| Mar 4 | KYMR | Kymera Therapeutics, Inc. | SSELL | 492 | $84.00 | $41.3K | -0.2% | Open the original filing on SEC.gov |
| Mar 2 | KYMR | Kymera Therapeutics, Inc. | AGRANT◆ | 35,300 | — | — | — | Open the original filing on SEC.gov |
| Mar 2 | KYMR | Kymera Therapeutics, Inc. | SSELL | 4,113 | $89.66 | $368.8K | -1.7% | Open the original filing on SEC.gov |
| Mar 2 | KYMR | Kymera Therapeutics, Inc. | SSELL | 1,424 | $88.50 | $126K | -0.6% | Open the original filing on SEC.gov |
| Mar 2 | KYMR | Kymera Therapeutics, Inc. | SSELL | 2,039 | $87.75 | $178.9K | -0.8% | Open the original filing on SEC.gov |
| Mar 2 | KYMR | Kymera Therapeutics, Inc. | AGRANT | 17,650 | — | — | +7.8% | Open the original filing on SEC.gov |
| Sep 17, 2025 | KYMR | Kymera Therapeutics, Inc. | MEXER◷◆ | 36,974 | — | — | — | Open the original filing on SEC.gov |
| Sep 17, 2025 | KYMR | Kymera Therapeutics, Inc. | MEXER◷◆ | 42,246 | — | — | — | Open the original filing on SEC.gov |
| Sep 17, 2025 | KYMR | Kymera Therapeutics, Inc. | SSELL◷ | 79,220 | $50.00 | $4M | -25.8% | Open the original filing on SEC.gov |
| Sep 17, 2025 | KYMR | Kymera Therapeutics, Inc. | MEXER◷ | 79,220 | $2.08 | $164.8K | +34.8% | Open the original filing on SEC.gov |